Evidence map›Paper›PMID 25900727›Full record

ArticleStem cells translational medicine2015

DNA damage response in neonatal and adult stromal cells compared with induced pluripotent stem cells.

Stefanie Liedtke, Sophie Biebernick, Teja Falk Radke, Daniela Stapelkamp, Carolin Coenen, Holm Zaehres, Gerhard Fritz, Gesine Kogler

Open access · goldAbstract readComparative Study
In one paragraph

Article in Stem cells translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Replication stress causes delayed mitotic entry and chromosome 12 fragility at the ANKS1B large neuronal gene in human induced pluripotent stem cells.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Article
  2. Article
  3. DNA repair fidelity in stem cell maintenance, health, and disease.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Stefanie LiedtkeInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Sophie BiebernickInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Teja Falk RadkeInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Daniela StapelkampInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Carolin CoenenInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Holm ZaehresInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Gerhard FritzInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Gesine KoglerInstitute for Transplantation Diagnostics and Cell Therapeutics and Institute of Toxicology, Heinrich-Heine-University Medical Center, Düsseldorf, Germany; Department Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Düsseldorf University Hospital · DEMax Planck Institute for Molecular Biomedicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledComprehensive analyses comparing individual DNA damage response (DDR) of induced pluripotent stem cells (iPSCs) with neonatal stromal cells with respect to their developmental age are limited. The imperative necessity of providing developmental age-matched cell sources for meaningful toxicological drug safety assessments in replacement of animal-based testing strategies is evident. Here, DDR after radiation or treatment with N-methyl-N-nitrosurea (MNU) was determined in iPSCs compared with neonatal and bone marrow stromal cells. Neonatal and adult stromal cells showed no significant morphologically detectable cytotoxicity following treatment with 1 Gy or 1 mM MNU, whereas iPSCs revealed a much higher sensitivity. Foci analyses revealed an effective DNA repair in stromal cell types and iPSCs, as reflected by a rapid formation and disappearance of phosphorylated ATM and γH2AX foci. Furthermore, quantitative polymerase chain reaction analyses revealed the highest basic expression level of DDR and repair-associated genes in iPSCs, followed by neonatal stromal cells and adult stromal cells with the lowest expression levels. In addition, the influence of genotoxic stress prior to and during osteogenic differentiation of neonatal and adult stromal cells was analyzed applying common differentiation procedures. Experiments presented here suggest a developmental age-dependent basic expression level of genes involved in the processing of DNA damage. In addition a differentiation-dependent downregulation of repair genes was observed during osteogenesis. These results strongly support the requirement to provide adequate cell sources for toxicological in vitro drug testing strategies that match to the developmental age and differentiation status of the presumptive target cell of interest. SIGNIFICANCE: The results obtained in this study advance the understanding of DNA damage processing in human neonatal stromal cells as compared with adult stromal cells and induced pluripotent stem cells (iPSCs). The data suggest developmental age-dependent differences in DNA damage repair capacity. In iPSCs (closest to embryonic stem cells), the highest expression level of DNA damage response and repair genes was found, followed by neonatal stromal cells and adult stromal cells with the lowest overall expression. In addition, a differentiation-dependent downregulation of repair capacity was observed during osteogenic differentiation in neonatal stromal cells. Notably, the impact of genotoxic stress on osteogenic differentiation depended on the time the genotoxic insult took place and, moreover, was agent-specific. These results strongly support the necessity of offering and establishing adequate cell sources for informative toxicological testing matching to the developmental age and differentiation status of the respective cell of interest.

Indexed as

DNA DamageAdultAlkylating AgentsAtaxia Telangiectasia Mutated ProteinsCell DifferentiationDrug Evaluation, PreclinicalFemaleHistonesHumansInduced Pluripotent Stem CellsInfant, NewbornMaleMethylnitrosoureaOsteogenesisPhosphorylationStromal CellsAlkylating AgentsAtaxia Telangiectasia Mutated ProteinsATM protein, humanH2AX protein, humanHistonesMethylnitrosoureaDNA damage responseDNA RepairIonizing radiationiPSCMNUMSCNeonatal and adult stromal cellsOsteogenesis

Identifiers

PMID25900727
PMCPMC4449092
OpenAlexW2156621580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.